Science Sparks @ ACTREC
.
13th October 2025Publications
- 1. Singh A, Natu A, Anthony F, Muthu H, Khade B, Smoot DT, Ashktorab H, Gupta S (2025). The synergistic action of HDAC inhibitor with cisplatin impedes survival and proliferation of drug-tolerant persister in gastric and liver cancer cells. Clinical Epigenetics.;17(1):168.
- Vatsa P, Chaudhary B, Kamble A, Waghmare S, Sharma S, Mandoli A (2025).Disrupting microtubule dynamics to rewire apoptosis, differentiation, and EMT programs in oral squamous cell carcinoma through indenamine derivatives. Bioorganic & Medicinal Chemistry.
Interesting Reads
Video of the Week
Liquid Biopsy: The Key to Unlocking a New Era of Precision Oncology
Upcoming Events
November 1-2, 2025
At ACTREC, Tata Memorial Centre, Kharghar
November 12-14, 2025
At ACTREC, Tata Memorial Centre, Kharghar
November 20-222, 2025
At ACTREC, Tata Memorial Centre, Kharghar
Do You Know?
In 2019, Targeted therapy Ribociclib, added to endocrine therapy improved survival in young women with certain types of breast cancer.
Cancer News
Nature, 08/10/2025
Scientists have used low-error genome-sequencing methods in normal tissues from large cohorts of individuals to scan for mutations that set the stage for cancer...
SciTechDaily, 07/10/2025
In studies using mouse models of breast, pancreatic, and muscle cancers, scientists have uncovered new evidence that a unique approach to stimulating the body’s natural immune defenses can help prevent cancer from returning and improve survival rates...
Sciencedaily, 07/10/2025
Scientists have discovered that bacteria living inside tumors can produce a molecule that fights cancer and enhances chemotherapy. The molecule, called 2-methylisocitrate (2-MiCit), was found to make colorectal cancer cells more vulnerable to chemotherapy by damaging...
© 2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)